Ambit Biosciences Corp's Chief Medical Officer was just granted 45,000 options


Athena Countouriotis, Ambit Biosciences Corp's Chief Medical Officer, just received 45,000 options from the company. The strike price of the options received was $10.80, and these expire on January 07, 2024. Countouriotis now owns at least 45,000 options on the company.

Some additional info was provided as follows:

1/4th of the shares subject to the option vests one year following the date of grant; thereafter, 1/48th of the shares subject to the option vests monthly over the next three years.

The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.

To receive a free e -mail notification whenever Ambit Biosciences Corp makes a similar move, sign up!

Other recent filings from the company include the following:

Written communication relating to an issuer or third party - Sept. 30, 2014
Ambit Biosciences: Entry Into A Material Definitive Agreement - Sept. 29, 2014
Written communication relating to third party tender offer - Sept. 29, 2014
Written communication relating to an issuer or third party - Sept. 29, 2014
Written communication relating to an issuer or third party - Sept. 29, 2014

   Auto Refresh

Feedback